1. Home
  2. TLSA vs CODA Comparison

TLSA vs CODA Comparison

Compare TLSA & CODA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • TLSA
  • CODA
  • Stock Information
  • Founded
  • TLSA 2013
  • CODA 1994
  • Country
  • TLSA United Kingdom
  • CODA United States
  • Employees
  • TLSA N/A
  • CODA N/A
  • Industry
  • TLSA Biotechnology: Pharmaceutical Preparations
  • CODA Industrial Machinery/Components
  • Sector
  • TLSA Health Care
  • CODA Industrials
  • Exchange
  • TLSA Nasdaq
  • CODA Nasdaq
  • Market Cap
  • TLSA 87.8M
  • CODA 92.5M
  • IPO Year
  • TLSA 2000
  • CODA N/A
  • Fundamental
  • Price
  • TLSA $1.57
  • CODA $6.94
  • Analyst Decision
  • TLSA
  • CODA Strong Buy
  • Analyst Count
  • TLSA 0
  • CODA 1
  • Target Price
  • TLSA N/A
  • CODA $11.00
  • AVG Volume (30 Days)
  • TLSA 460.2K
  • CODA 46.2K
  • Earning Date
  • TLSA 05-20-2025
  • CODA 06-11-2025
  • Dividend Yield
  • TLSA N/A
  • CODA N/A
  • EPS Growth
  • TLSA N/A
  • CODA 61.24
  • EPS
  • TLSA N/A
  • CODA 0.34
  • Revenue
  • TLSA N/A
  • CODA $21,064,685.00
  • Revenue This Year
  • TLSA N/A
  • CODA $11.64
  • Revenue Next Year
  • TLSA N/A
  • CODA $14.53
  • P/E Ratio
  • TLSA N/A
  • CODA $20.08
  • Revenue Growth
  • TLSA N/A
  • CODA 15.63
  • 52 Week Low
  • TLSA $0.54
  • CODA $5.76
  • 52 Week High
  • TLSA $1.91
  • CODA $9.89
  • Technical
  • Relative Strength Index (RSI)
  • TLSA 64.57
  • CODA 58.52
  • Support Level
  • TLSA $1.49
  • CODA $6.41
  • Resistance Level
  • TLSA $1.78
  • CODA $6.95
  • Average True Range (ATR)
  • TLSA 0.18
  • CODA 0.38
  • MACD
  • TLSA 0.04
  • CODA 0.05
  • Stochastic Oscillator
  • TLSA 71.23
  • CODA 78.78

About TLSA Tiziana Life Sciences Ltd.

Tiziana Life Sciences Ltd is a clinical-stage biotechnology company that specializes in the developing transformative therapies for neurodegenerative and lung diseases. Its clinical pipeline includes drug assets for Secondary Progressive Multiple Sclerosis, ALS. Alzheimer's, Crohn's Disease and KRAS+ NSCLC. Tiziana is led by a team of qualified executives with extensive drug development and commercialization experience.

About CODA Coda Octopus Group Inc. Common stock

Coda Octopus Group Inc develops underwater technologies and equipment for imaging, mapping defense, and survey applications. It operates in two segments: Marine Technology Business and Marine Engineering Business. The Technology Business develops proprietary solutions for both the commercial and defense subsea market. Its solutions include hardware and software for Geophysical Systems, Motion & Positioning Systems, and Real-Time Volumetric Imaging Sonar. The Engineering Business segment provides engineering services to a range of clients in the defense markets. Its geographical segments are the Americas, Europe, Australia/Asia, and the Middle East/Africa. The majority of revenue is derived from the Marine Technology Business segment.

Share on Social Networks: